Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
+16.09%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$40B
AUM Growth
+$3.9B
(+11%)
Cap. Flow
-$832M
Cap. Flow
% of AUM
-2.08%
Top 10 Holdings %
Top 10 Hldgs %
16.59%
Holding
767
New
63
Increased
267
Reduced
289
Closed
81
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$759M |
| 2 |
DuPont de Nemours
DD
|
$200M |
| 3 |
Ross Stores
ROST
|
$182M |
| 4 |
Emerson Electric
EMR
|
$159M |
| 5 |
Honeywell
HON
|
$146M |
Top Sells
| 1 |
Wayfair
W
|
$363M |
| 2 |
GE Aerospace
GE
|
$314M |
| 3 |
Deere & Co
DE
|
$194M |
| 4 |
Caterpillar
CAT
|
$168M |
| 5 |
Waste Management
WM
|
$145M |
Sector Composition
| 1 | Healthcare | 15.94% |
| 2 | Technology | 14.77% |
| 3 | Financials | 12.36% |
| 4 | Consumer Discretionary | 11.45% |
| 5 | Industrials | 10.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Ally Financial
ALLY
$12.7B
| $47.8M | 0.12% |
1,740,000
+200,000
| +13% | +$5.5M |
|
202
Capital One
COF
$142B
| $47.8M | 0.12% |
585,082
-339,400
| -37% | -$27.7M |
|
203
Arthur J. Gallagher & Co
AJG
$76.7B
| $47.6M | 0.12% |
610,100
+313,300
| +106% | +$24.5M |
|
204
Global Payments
GPN
$21.3B
| $47.5M | 0.12% |
+348,122
| New | +$47.5M |
|
|
AGN
205
DELISTED
Allergan plc
AGN
| $47.5M | 0.12% |
324,469
-34,210
| -10% | -$5.01M |
|
206
Lear
LEA
$5.91B
| $47.5M | 0.12% |
+350,000
| New | +$47.5M |
|
207
American International
AIG
$43.9B
| $47.1M | 0.12% |
1,092,721
-17,400
| -2% | -$749K |
|
208
AES
AES
$9.21B
| $47M | 0.12% |
2,601,433
+1,786,800
| +219% | +$32.3M |
|
209
Marvell Technology
MRVL
$54.6B
| $47M | 0.12% |
2,361,367
+957,000
| +68% | +$19M |
|
|
FSR
210
DELISTED
Fisker Inc.
FSR
| $46.7M | 0.12% |
4,752,000
| – | – |
|
211
SS&C Technologies
SSNC
$21.7B
| $46.2M | 0.12% |
725,000
+110,000
| +18% | +$7.01M |
|
212
Humana
HUM
$37B
| $45.2M | 0.11% |
170,110
-700
| -0.4% | -$186K |
|
213
Estee Lauder
EL
$32.1B
| $45.2M | 0.11% |
272,784
+125,100
| +85% | +$20.7M |
|
|
STML
214
DELISTED
Stemline Therapeutics, Inc.
STML
| $45M | 0.11% |
3,500,000
+2,789,986
| +393% | +$35.9M |
|
215
Aflac
AFL
$57.2B
| $44.7M | 0.11% |
894,074
+186,000
| +26% | +$9.3M |
|
|
DRNA
216
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $44.7M | 0.11% |
3,050,000
| – | – |
|
217
Takeda Pharmaceutical
TAK
$48.6B
| $44M | 0.11% |
+2,160,000
| New | +$44M |
|
218
Marriott International Class A Common Stock
MAR
$71.9B
| $43.8M | 0.11% |
350,325
-700
| -0.2% | -$87.6K |
|
|
NVRO
219
DELISTED
NEVRO CORP.
NVRO
| $43.8M | 0.11% |
700,000
+592,500
| +551% | +$37M |
|
220
HCA Healthcare
HCA
$98.5B
| $43.6M | 0.11% |
334,200
-300
| -0.1% | -$39.1K |
|
|
XLNX
221
DELISTED
Xilinx Inc
XLNX
| $43.4M | 0.11% |
342,410
-94,100
| -22% | -$11.9M |
|
222
EOG Resources
EOG
$64.4B
| $43.4M | 0.11% |
455,500
+85,400
| +23% | +$8.13M |
|
223
Williams Companies
WMB
$69.9B
| $43.2M | 0.11% |
1,505,300
+828,700
| +122% | +$23.8M |
|
224
Toyota
TM
$260B
| $43M | 0.11% |
364,208
+115,000
| +46% | +$13.6M |
|
225
Celanese
CE
$5.34B
| $42.9M | 0.11% |
+435,400
| New | +$42.9M |
|